2021 annual financial data
ProQR Therapeutics 2021 Operating margin
Direct answer
Operating margin was -4,285.39%.
Operating income was -57,210,000 EUR and net income was -60,740,000 EUR.
Operating cash flow was -26,012,000 EUR.
Get free ProQR Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,335,000 EUR
- Operating income
- -57,210,000 EUR
- Net income
- -60,740,000 EUR
- Operating cash flow
- -26,012,000 EUR